Johnson & Johnson (NYSE:JNJ) on Friday announced topline results from Phase 3b APEX study of Tremfya (guselkumab) in patients ...

Vera Therapeutics completes enrollment in Phase 3 atacicept trial for IgAN, with interim efficacy results expected this ...

Target 2x Long MSTR ETF offers even further leverage on MSTR, and therefore BTC. See why I rate MSTX fund a strong sell.

Analysts currently expect the company to post earnings of $2.27 per share on revenue of $2.12 billion for the quarter.

Cutting through the confusion is the 2025 AI Index from Stanford University’s Institute for Human-Centered Artificial ...

Gap Inc. stock offers value with a P/E below 10x, strong brand growth, a 3.5% dividend yield, and potential upside from trade ...

Based on a survey of 180 global asset owners, with investment portfolios ranging from US$1 billion to over US$500 billion, the findings highlight a growing focus on alternative investments, ...

New research uncovers how global crises and generative AI disrupted academic writing norms across 90+ countries.Alicante, Spain--(Newsfile Corp.

InvestorPlace CEO Brian Hunt reminded us that free markets, innovation, and productive enterprise have allowed mankind to ...

Company Insights examined data from PitchBook's NVCA quarterly report to explore gender disparities in startup funding.

It’s like having the data capabilities of Morningstar combined with the flexibility of Excel and the visualization of charts – all integrated into one tool. Stock Rover is entirely web-based ...

Researchers have described how tropical cyclones in the Caribbean could become more frequent after analyzing sediment from ...